Overview
Art Sedrakyan is a Professor at Weill Cornell Medical College and is also leading US Food and Drug Administration’s (FDA) Medical Device Epidemiology (MDEpiNet) Coordinating, Science and Infrastructure Center http://hpr.weill.cornell.edu/research/mdepinet/mdepinet.html. see main http://www.mdepinet.org/
At Cornell he also directs the 'Institute for Health Technologies and Interventions'. https://hpr.weill.cornell.edu/research-collaboration/our-divisions/health-technologies-interventions
He is a trained CT surgeon and a graduate of Johns Hopkins University with Ph.D in Health Policy and Management. He was a senior adviser at FDA and had appointments as senior service officer/senior adviser at the Agency for Healthcare Research and Quality (AHRQ) from 2005 to 2009. He was a lead adviser on interventions (including surgery), implantable devices and cardiovascular and orthopedic content areas. Art Sedrakyan initiated the Effective Healthcare Cardiovascular Consortium and supervised centers for Education and Research in Therapeutics (CERTS); Cardiovascular CERT and orthopedic Device CERT.
Prior to appointments at DHHS he worked in the United Kingdom and has registry research, evidence synthesis and teaching experience from Royal College of Surgeons (RCS) of England and London School of Hygiene (LSHTM), where he served as a faculty and was Senior Adviser for National Collaborating Center for Acute Care (part of UK National Institute of Clinical Excellence (NICE)).
He is currently serving as a ranking member and was previously the Vice-Chair of Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). He is serving on MEDCAC from June 1, 2010. http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/MEDCAC.html. Dr. Sedrakyan is the Vice-Chair of the IDEAL initiative with special interest/leadership area in devices (www.ideal-collaboration.net). The IDEAL is the main international organization dealing with technology innovation and its evaluation. Since January 2017 he is serving as specialist advisor for Australian Therapeutic Good Administration (TGA) and Honorary Professor at the University of New South Wales in Sydney Australia where MDEpiNet chapter is established.
Highlights
- 1Journal of vascular surgery · 2022
- 2BMJ (Clinical research ed.) · 2022
- 3The Journal of urology · 2020
Publications
Funding
Active
4 grants- PIData Analytical ServicesAbdominal Core Health Quality Collaborative · 2022–2028ContractSA 226876-6
- Co-IProstate Cancer Comparative Outcomes of New Conceptual Paradigms for Treatment (PC CONCEPT)Patient-Centered Outcomes Research Institute · 2020–2027PCORI CER-2019C1-15682
- KPLeveraging linked registry and electronic health records to examine long-term patient outcomes after peripheral vascular intervention"National Heart, Lung, and Blood Institute · 2021–2027CareerK01HL159315-01
- Sub-PIFederated Ecosystem for Analytics and Standardization Technologies. FEASTARPA-H · 2024–2026 · via DNA Hive, LLCFEAST-ORG-002
Completed grants (13)
- Co-IEvaluation of Transperineal Biopsy under Local Anesthesia, a Novel approach to Decrease Post-Biopsy Infections and Improve Cancer DetectionNational Cancer Institute · 2020–2025
- PINovel Approaches to Advance Coordinated Registry Networks (CRNs).United States Food & Drug Administration · 2020–2025U01FD006936-04
- MPIIncorporating learning effects into medical device active safety surveillance methodsNational Heart, Lung, and Blood Institute · 2020–2025 · via Vanderbilt University Medical CenterR01HL149948-05
- PIDATA ANALYTICAL SERVICESThe Americas Hernia Society Quality Collaborative · 2019–2023ContractSA 194399-04
- Sub-PIJohns Hopkins Center of Excellence in Regulatory Science and Innovation (JHCERSI)United States Food & Drug Administration · 2019–2021 · via The Johns Hopkins UniversityU01FD005942-05
- PICreating National Surveillance Infrastructure for Priority Medical DevicesUnited States Food & Drug Administration · 2015–2021· 2 renewalsU01FD005478-05
- Sub-PISynthetic Mid-Urethral Slings for Stress Urinary Incontinence in WomenUnited States Food & Drug Administration · 2018–2021 · via Vanderbilt University Medical Center· 8 renewalsU01FD006292-02
- PICA Amendment No. 1Stefan Dabic · 2018–2019ContractCA 190625-01
- Co-IDeveloping Evidence for Safety Surveillance from Device Adverse Event ReportsAgency for Healthcare Research and Quality · 2018–2019R03HS026291-01
- PIThe Abiomed and MDEPINET Public Private Parternship (PPP)Abiomed R&D, Inc. · 2018–2019ContractSRA 183748-01
- PIMDEpiNet: MCM (Medical Countermeasures)United States Food & Drug Administration · 2012–2018U01FD004494-01
- PIGlobal Consortium of Cardiovascular Registries: Transcatheter Valve initiativeNIH · 2013–2018 · via NIH RePORTER
- Sub-PIImproving Quality: Outcomes and Patient SatisfactionNew York State Department of Health · 2015–2017 · via New York Presbyterian HospitalNYPH 15050722-02
Clinical research
Active
2 studies- PIMultispecialty Data Repository for Advanced Imaging and Therapeutic InterventionsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
- PIUse and outcomes of new medical technologies in the treatment of gastrointestinal, lung, and ovarian cancerWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2021)
News mentions
- Study Shows Importance of Linked Databases for Long-Term Device SurveillanceOctober 25, 2022
By linking a national vascular registry with medical data records in Medicare claims for patients who underwent endovascular abdominal aortic aneurysm repair, researchers were able to identify which devices posed the most risk for reintervention.
- Awards and Honors Across Weill Cornell Medicine - June 28, 2019June 28, 2019
Awards, honors, prizes and achievements for the month of June.